Literature DB >> 25834321

Hepatectomy with primary closure of common bile duct for hepatolithiasis combined with choledocholithiasis.

Chang-Ku Jia1, Jie Weng1, You-Ke Chen1, Qing-Zhuang Yang1, Yu Fu1, Qi-Fan Qin1, Wei-Ming Yu1.   

Abstract

AIM: To evaluate the feasibility of hepatectomy and primary closure of common bile duct for intrahepatic and extrahepatic calculi.
METHODS: From January 2008 to May 2013, anatomic hepatectomy followed by biliary tract exploration without biliary drainage (non-drainage group) was performed in 43 patients with intrahepatic and extrahepatic calculi. After hepatectomy, flexible choledochoscopy was used to extract residual stones and observe the intrahepatic bile duct and common bile duct (CBD) for determination of biliary stricture and dilatation. Function of the sphincter of Oddi was determined by manometry of the CBD. Primary closure of the CBD without T-tube drainage or bilioenteric anastomosis was performed when there was no biliary stricture or sphincter of Oddi dysfunction. Dexamethasone and anisodamine were intravenously injected 2-3 d after surgery to prevent postoperative retrograde infection due to intraoperative bile duct irrigation, and to maintain relaxation of the sphincter of Oddi, respectively. During the same period, anatomic hepatectomy followed by biliary tract exploration with biliary drainage (drainage group) was performed in 48 patients as the control group. Postoperative complications and hospital stay were compared between the two groups.
RESULTS: There was no operative mortality in either group of patients. Compared to intrahepatic and extrabiliary drainage, hepatectomy with primary closure of the CBD (non-drainage) did not increase the incidence of complications, including residual stones, bile leakage, pancreatitis and cholangitis (P > 0.05). Postoperative hospital stay and costs were nevertheless significantly less in the non-drainage group than in the drainage group. The median postoperative hospital stay was shorter in the non-drainage group than in the drainage group (11.2 ± 2.8 d vs 15.4 ± 2.1 d, P = 0.000). The average postoperative cost of treatment was lower in the non-drainage group than in the drainage group (29325.6 ± 5668.2 yuan vs 32933.3 ± 6235.1 yuan, P = 0.005).
CONCLUSION: Hepatectomy followed by choledochoendoscopic stone extraction without biliary drainage is a safe and effective treatment of hepatolithiasis combined with choledocholithiasis.

Entities:  

Keywords:  Biliary drainage; Choledocholithiasis; Hepatectomy; Hepatolithiasis; Primary closure

Mesh:

Substances:

Year:  2015        PMID: 25834321      PMCID: PMC4375578          DOI: 10.3748/wjg.v21.i12.3564

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  Long-term results of choledochoduodenostomy in the treatment of choledocholithiasis: assessment of 225 cases.

Authors:  P Parrilla; P Ramirez; F Sanchez Bueno; J M Perez; M F Candel; M S Muelas; R Robles
Journal:  Br J Surg       Date:  1991-04       Impact factor: 6.939

2.  Middle and long-term clinical outcomes of patients with regional hepatolithiasis after subcutaneous tunnel and hepatocholangioplasty with utilization of the gallbladder.

Authors:  Xu Li; Li Shi; Yu Wang; Fu-Zhou Tian
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-11

3.  Outcomes of hepatectomy for hepatolithiasis.

Authors:  Tung-Yen Lee; Yao-Li Chen; Hung-Chi Chang; Chien-Pin Chan; Shou-Jen Kuo
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

4.  Indications and therapeutical options in hepatolithiasis.

Authors:  J M Ramia; A Palomeque; K Muffak; J Villar; D Garrote; J A Ferrón
Journal:  Rev Esp Enferm Dig       Date:  2006-08       Impact factor: 2.086

5.  Liver resection for intrahepatic stones.

Authors:  Moon-Tong Cheung; Philip Chong-Hei Kwok
Journal:  Arch Surg       Date:  2005-10

6.  [Liver resection in the treatment of intrahepatic lithiasis. Immediate and long-term results in a single-center series].

Authors:  C Marín; R Robles; P Pastor; P Parrilla
Journal:  Rev Esp Enferm Dig       Date:  2008-04       Impact factor: 2.086

7.  Liver resection as the definitive treatment for unilateral non-oriental primary intrahepatic lithiasis.

Authors:  Paulo Herman; Marcos V Perini; Marcel Autran C Machado; Telesforo Bacchella; Vincenzo Pugliese; William A Saad; Jose Eduardo M da Cunha; Marcel C C Machado; Joaquim Gama Rodrigues
Journal:  Am J Surg       Date:  2006-04       Impact factor: 2.565

8.  Bile duct injuries related to misplacement of "T tubes".

Authors:  Miguel Angel Mercado; Carlos Chan; Héctor Orozco; Alexandra Barajas Olivas; José Manuel Villalta; Ismael Domínguez; Javier Eraña; Fernando Poucel
Journal:  Ann Hepatol       Date:  2006 Jan-Mar       Impact factor: 2.400

9.  Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries.

Authors:  M Lesurtel; J M Regimbeau; O Farges; M Colombat; A Sauvanet; J Belghiti
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-09       Impact factor: 2.566

10.  Primary duct closure versus T-tube drainage following exploration of the common bile duct.

Authors:  J A Williams; P J Treacy; P Sidey; C S Worthley; N C Townsend; E A Russell
Journal:  Aust N Z J Surg       Date:  1994-12
View more
  2 in total

1.  Biliary tract exploration through a common bile duct incision or left hepatic duct stump in laparoscopic left hemihepatectomy for left side hepatolithiasis: which is better?: A single-center retrospective case-control study.

Authors:  Xintao Zeng; Pei Yang; Wentao Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

2.  LIVER RESECTION FOR NON-ORIENTAL HEPATOLITHIASIS.

Authors:  Orlando Jorge Martins Torres; Marcelo Moura Linhares; Eduardo José B Ramos; Paulo Cezar G Amaral; Marcos Belotto; Angelica Maria Lucchese; Romerito Fonseca Neiva; Theago Medeiros Freitas; Rodolfo Santana; Josiel Paiva Vieira; Jaldo Santos Freire; Camila Cristina S Torres; Antonio Nocchi Kalil
Journal:  Arq Bras Cir Dig       Date:  2019-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.